Not rendering correctly? View this email as a web page here.
A monthly preview of the top stories on the COVID-19 Pandemic
April 8, 2020
Focus Feature: COVID-19/SARS-CoV-2
As part of our April issue of DDNews, we include a special four-page section providing an overview on R&D around the novel coronavirus. Coverage includes efforts to develop vaccines against the virus, research on potential therapeutics for COVID-19 and work being conducted on diagnostics to detect SARS-CoV-2 infection...more >

In addition to the broader feature above, check out the links below for additional COVID-19 R&D news highlights.
Ferreting out a COVID-19 animal model
Texas Biomed creates multi-species study to identify appropriate COVID-19 animal models...more >
A consortium against COVID
The newly established COVID-19 Genomics UK Consortium unites government, public health and research organizations to conduct sequencing studies of the virus and its transmission...more >
Purdue researchers leap to discover more about coronavirus
University provides an overview of ongoing COVID-19 R&D efforts, many of which began in February...more >
A COVID-19 vaccine candidate emerges
Johnson & Johnson reveals its selection of a lead vaccine against the novel coronavirus and shares its plans so far for progression...more >
Indian researchers team up on antiviral drug for COVID-19
After IICT initially narrowed down prospects to 15 candidates, the collaborators settle on favipiravir, remdesivir and baloxavir as initial promising leads...more >
A potential coronavirus treatment eyes a patent
XORTX files a provisional patent for potential treatment of respiratory and kidney disease injury due to coronavirus infection, and eyes the possibility that the compound might be able to treat COVID-19 itself...more >
Duke looks to protect healthcare professionals in midst of pandemic
University’s Clinical Research Institute expedites study of COVID-19 prevention in healthcare workers...more >
A molecular POC test for COVID-19 finds funding
Mesa Biotech receives funding from U.S. Health and Human Services for development of a 30-minute molecular point-of-care SARS-CoV-2 Test...more >
Vela Diagnostics moves ahead on coronavirus test
As it awaits official approval on SARS-CoV-2 diagnostic, the company seeks emergency use authorization and works on an assay with Great Basin Scientific...more >